Smithfield Trust’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-90
| Closed | -$5K | – | 1079 |
|
|
2021
Q3 | $5K | Hold |
90
| – | – | ﹤0.01% | 1002 |
|
|
2021
Q2 | $6K | Sell |
90
-908
| -91% | -$60.5K | ﹤0.01% | 945 |
|
|
2021
Q1 | $92K | Sell |
998
-32
| -3% | -$2.95K | 0.01% | 454 |
|
|
2020
Q4 | $92K | Buy |
1,030
+94
| +10% | +$8.4K | 0.01% | 439 |
|
|
2020
Q3 | $96K | Sell |
936
-232
| -20% | -$23.8K | 0.01% | 401 |
|
|
2020
Q2 | $92K | Sell |
1,168
-142
| -11% | -$11.2K | 0.01% | 398 |
|
|
2020
Q1 | $76K | Sell |
1,310
-182
| -12% | -$10.6K | 0.01% | 377 |
|
|
2019
Q4 | $80K | Sell |
1,492
-430
| -22% | -$23.1K | 0.01% | 443 |
|
|
2019
Q3 | $100K | Sell |
1,922
-962
| -33% | -$50.1K | 0.01% | 393 |
|
|
2019
Q2 | $139K | Buy |
2,884
+72
| +3% | +$3.47K | 0.01% | 332 |
|
|
2019
Q1 | $142K | Buy |
2,812
+366
| +15% | +$18.5K | 0.02% | 311 |
|
|
2018
Q4 | $145K | Buy |
2,446
+1,790
| +273% | +$106K | 0.02% | 283 |
|
|
2018
Q3 | $43K | Hold |
656
| – | – | ﹤0.01% | 550 |
|
|
2018
Q2 | $33K | Sell |
656
-28
| -4% | -$1.41K | ﹤0.01% | 592 |
|
|
2018
Q1 | $36K | Buy |
684
+664
| +3,320% | +$34.9K | ﹤0.01% | 551 |
|
|
2017
Q4 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 1083 |
|